The takeaway
HealthEquity Inc shows a pronounced seasonal pattern over 10 years of data — strongest in January (+7.1%) and softest in December (−7.6%).
Right now
In July, the stock has fallen 30% of years, averaging −1.1%, roughly 3.3 pts behind the S&P 500.
The full picture
HealthEquity Inc's most dependable month has been January, higher in 8 of 10 years; December has been its least reliable, up just 10% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in January (+7.3 pts); it has trailed the market most in December (−8.6 pts).
“vs S&P” is HealthEquity Inc’s average for a month minus the S&P 500’s average for that same month — isolating HealthEquity Inc’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, January has closed higher 100% of the time versus 80% across the last 10 years — the pattern is strengthening.
Figures are the typical (median) January return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
This is a stock you can almost set a calendar by, and January is the anchor — it has closed higher in 8 of 10 Januaries, the steadiest beat on its year.
The strength looks broad-based rather than freakish: its average (+7.1%) and median (+11.5%) sit close together, so no single blow-out year is flattering the figure. That reliability comes with real swings, mind — even January ranges by 10.7% from year to year, so any single year can land far from the average. Better still, that strength is the stock's own and not just a buoyant market — January has outpaced the S&P 500 by +7.3 points on average. Few peers keep such company in January — the typical stock clears it just 53% of the time.
It doesn't stand entirely alone — February, May, and June have leaned firm as well, if less emphatically. At the other end of the calendar, December has been the soft spot — the weakest of 3 months that average a loss (−7.6%), and the edge isn't year-round — the stock has trailed the S&P 500 in December, March, and July. Its roughest month on record was a −33.5% December in 2018 — a reminder of how hard even a seasonal name can fall.
January has now closed higher 5 years running. If anything it has sharpened recently — the last five Januaries run ahead of the earlier years.
For a stock this dependable in January, the sharper question is the rest of the year — outside its strong stretch, the calendar gives far less to lean on.
Short answers on the stock's best month (January), its worst (December), and whether it really trades seasonally.
Yes, to a pronounced degree. Since 2016 its best month (January, +7.1%) has run well ahead of its worst (December, −7.6%) — the heatmap above shows how steady that gap has been year to year.
January has been the strongest, averaging +7.1% and closing higher in 8 of 10 years since 2016.
It's the weakest, averaging −7.6% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade